BioSpace News Archive

Biotech Beach

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

MediciNova, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 for the treatment of chlorine-induced acute respiratory distress syndrome.

May 14, 2024
·
5 min read
Biotech Bay

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis, Inc., a leading enzyme engineering company, announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing.

May 14, 2024
·
9 min read
Business

Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, reported its financial results for the first quarter ended March 31, 2024, and provided a business update.

May 14, 2024
·
14 min read
Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024

Aurinia Pharmaceuticals Inc., announced the presentation of results from an updated cost-effective analysis of LUPKYNIS, a second generation calcineurin inhibitor, at the annual National Kidney Foundation Spring Clinical Meeting 2024 taking place in Long Beach, CA, May 14-18.

May 14, 2024
·
11 min read
Business

Immatics Announces First Quarter 2024 Financial Results and Business Update

Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, provided a business update and reported financial results for the quarter ended March 31, 2024.

May 14, 2024
·
20 min read
Biotech Beach

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit

Zentalis® Pharmaceuticals, Inc. announced that members of the management team will participate in a virtual fireside chat during the TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO and EHA on May 28, 2024 at 10:30 a.m. ET.

May 14, 2024
·
2 min read
Business

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

Mural Oncology plc announced financial results for the first quarter of 2024 and provided a business update.

May 14, 2024
·
12 min read
Drug Development

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA®, a dual oral inhibitor of SGLT2 and SGLT1, reduced the risk of heart failure-related events across a diverse population of patients, including patients with preserved ejection fraction.

May 14, 2024
·
10 min read
BioCapital

ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder

Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.

May 14, 2024
·
4 min read
Drug Development

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity

Biophytis SA announces the design of its phase 2 OBA clinical study in obesity with BIO101.

May 14, 2024
·
4 min read